Circassia Pharmaceuticals's total assets for Q4 2025 were £76.20M, an increase of 7.32% from the previous quarter. GB:NIOX total liabilities were £8.60M for the fiscal quarter, a 30.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.